These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 31018961)
21. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. Frank MB; McCubbin V; Trieu E; Wu Y; Isenberg DA; Targoff IN J Autoimmun; 1999 Mar; 12(2):137-42. PubMed ID: 10047434 [TBL] [Abstract][Full Text] [Related]
22. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Yeker RM; Pinal-Fernandez I; Kishi T; Pak K; Targoff IN; Miller FW; Rider LG; Mammen AL; Ann Rheum Dis; 2018 May; 77(5):714-719. PubMed ID: 29363513 [TBL] [Abstract][Full Text] [Related]
23. Myositis-Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality. Sherman MA; Noroozi Farhadi P; Pak K; Trieu EP; Sarkar K; Targoff IN; Neely ML; Mammen AL; Rider LG; Arthritis Rheumatol; 2024 Jun; 76(6):963-972. PubMed ID: 38272842 [TBL] [Abstract][Full Text] [Related]
24. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Hirakata M; Suwa A; Takada T; Sato S; Nagai S; Genth E; Song YW; Mimori T; Targoff IN Arthritis Rheum; 2007 Apr; 56(4):1295-303. PubMed ID: 17393393 [TBL] [Abstract][Full Text] [Related]
25. Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease. Li L; Wang H; Wang Q; Wu C; Liu C; Zhang Y; Cheng L; Zeng X; Zhang F; Li Y J Neurol Sci; 2019 Feb; 397():123-128. PubMed ID: 30616054 [TBL] [Abstract][Full Text] [Related]
27. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies. Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268 [TBL] [Abstract][Full Text] [Related]
28. Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies. Perron MM; Vasquez-Canizares N; Tarshish G; Wahezi DM Pediatr Rheumatol Online J; 2021 Jun; 19(1):92. PubMed ID: 34118936 [TBL] [Abstract][Full Text] [Related]
29. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy. Huang HL; Lin WC; Yeh CC; Sun YT J Clin Neurosci; 2020 Apr; 74():32-35. PubMed ID: 31982271 [TBL] [Abstract][Full Text] [Related]
30. Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies. Ueki M; Kobayashi I; Takezaki S; Tozawa Y; Okura Y; Yamada M; Kuwana M; Ariga T Mod Rheumatol; 2019 Mar; 29(2):351-356. PubMed ID: 29532710 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients. Mathiesen PR; Buchvald F; Nielsen KG; Herlin T; Friis T; Nielsen S Rheumatology (Oxford); 2014 Apr; 53(4):644-9. PubMed ID: 24310298 [TBL] [Abstract][Full Text] [Related]
32. [The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis]. Li DM; Wang L; Liu MY; Xu L; Tang XM Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):966-972. PubMed ID: 33256317 [No Abstract] [Full Text] [Related]
33. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features. Sherman MA; Graf R; Sabbagh SE; Galindo-Feria AS; Pinal-Fernandez I; Pak K; Kishi T; Flegel WA; Targoff IN; Miller FW; Lundberg IE; Rider LG; Mammen AL; Rheumatology (Oxford); 2023 Feb; 62(SI2):SI226-SI234. PubMed ID: 35961028 [TBL] [Abstract][Full Text] [Related]
34. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review]. Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559 [No Abstract] [Full Text] [Related]
35. Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies. Arase N; Tsuji H; Takamatsu H; Jin H; Konaka H; Hamaguchi Y; Tonomura K; Kotobuki Y; Ueda-Hayakawa I; Matsuoka S; Hirano T; Yorifuji H; Murota H; Ohmura K; Nakashima R; Sato T; Kumanogoh A; Katayama I; Arase H; Fujimoto M J Autoimmun; 2022 Jan; 126():102774. PubMed ID: 34896887 [TBL] [Abstract][Full Text] [Related]
36. Autoantibodies reactive to PEP08 are clinically related with morbidity and severity of interstitial lung disease in connective tissue diseases. Okumura M; Ozawa T; Hamana H; Norimatsu Y; Tsuda R; Kobayashi E; Shinoda K; Taki H; Tobe K; Imura J; Sugiyama E; Kishi H; Muraguchi A Eur J Immunol; 2018 Oct; 48(10):1717-1727. PubMed ID: 29989658 [TBL] [Abstract][Full Text] [Related]
37. Myositis Autoantibody Profiles and Clinical Significance in Patients with Inflammatory Myopathies in Southwest China. Zhu H; Zhou W; Zheng L; Jiang Y; Lao Y; Li S; Jin M; Wang J; Li X Clin Lab; 2024 May; 70(5):. PubMed ID: 38747930 [TBL] [Abstract][Full Text] [Related]
38. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China. Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248 [TBL] [Abstract][Full Text] [Related]
39. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW; Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355 [TBL] [Abstract][Full Text] [Related]
40. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]